Biotechnology - Cardiff, Wales, United Kingdom
Cell Therapy Limited (CTL) was founded in 2009 by Nobel Laureate, Professor Martin Evans and Ajan Reginald, ex-Global Head of Emerging Technologies, Roche. CTL's mission is to develop Regenerative Medicines for Life - to discover and develop Regenerative Medicines to treat Life threatening and Life altering diseases. CTL's team includes world-class scientists (Nobel laureate, President of American Society) and clinicians (Clinical Professors of Heart surgery, Cell Therapy from top universities Oxford, Toronto and Peking) led by experienced management (ex-Roche) and an active Board and Scientific advisory committee of world experts. We apply our extensive regenerative medicine patent portfolio and expertise to areas of high unmet clinical need. Through our integrated infrastructure and global network of collaborations we complete clinical trials in a fraction of normal time.
WordPress.org
Mobile Friendly
YouTube